1. Home
  2. FFIC vs SLDB Comparison

FFIC vs SLDB Comparison

Compare FFIC & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flushing Financial Corporation

FFIC

Flushing Financial Corporation

HOLD

Current Price

$15.38

Market Cap

536.1M

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$6.69

Market Cap

498.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIC
SLDB
Founded
1929
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.1M
498.6M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
FFIC
SLDB
Price
$15.38
$6.69
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$16.80
$14.70
AVG Volume (30 Days)
214.8K
1.1M
Earning Date
04-28-2026
01-01-0001
Dividend Yield
5.62%
N/A
EPS Growth
N/A
36.65
EPS
0.43
N/A
Revenue
$6,947,000.00
$8,094,000.00
Revenue This Year
$14.57
N/A
Revenue Next Year
$6.64
N/A
P/E Ratio
$36.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.65
$2.45
52 Week High
$17.79
$7.37

Technical Indicators

Market Signals
Indicator
FFIC
SLDB
Relative Strength Index (RSI) 39.34 57.46
Support Level $14.44 $5.08
Resistance Level $15.57 $7.05
Average True Range (ATR) 0.46 0.47
MACD -0.12 0.00
Stochastic Oscillator 13.43 94.74

Price Performance

Historical Comparison
FFIC
SLDB

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: